|
1 |
OTHR-04. Development of a functional plattform for real-time personalized drug sensitivity profiling of patient-derived 3D fresh tumor tissue cultures in the pediatric precision oncology program INFORM [Abstract]
Peterziel, Heike. - Augsburg : Universität Augsburg, 2023
|
|
|
|
2 |
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Darwish, Salma. - Freiburg : Universität, 2022
|
|
|
|
3 |
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
Peterziel, Heike. - Augsburg : Universität Augsburg, 2022
|
|
|
|
4 |
First fluorescent acetylspermidine deacetylation assay for HDAC10 identifies selective inhibitors with cellular target engagement
Herp, Daniel. - Freiburg : Universität, 2022
|
|
|
|
5 |
iTReX: Interactive exploration of mono- and combination therapy dose response profiling data
ElHarouni, Dina. - Augsburg : Universität Augsburg, 2022
|
|
|
|
6 |
Patient-by-patient deep transfer learning for drug-response profiling using confocal fluorescence microscopy of pediatric patient-derived tumor-cell spheroids
Berker, Yannick. - Augsburg : Universität Augsburg, 2022
|
|
|
7 |
First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement **
Enthalten in ChemBioChem 10.06.2022. 1 S.
|
|
|
|
8 |
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
Alhalabi, Karam T.. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2021
|
|
|
|
9 |
Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors
Enthalten in ChemMedChem Bd. 15, 2020, Nr. 13: 1163-1174. 12 S.
|
|
|
|
10 |
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment
Shen, Jing. - Freiburg : Universität, 2019
|
|
Administration
